クルクミン
分子式: | C21H20O6 |
その他の名称: | クルクミン、Curcumin、(1E,6E)-1,7-Bis(4-hydroxy-3-methylphenyl)-1,6-heptadiene-3,5-dione、(1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione、C.I.Natural Yellow 3、C.I.75300、C.I.ナチュラルイエロー3、ジフェルロイルメタン、Diferuloylmethane、trans,trans-クルクミン、trans,trans-Curcumin |
体系名: | (1E,6E)-1,7-ビス(4-ヒドロキシ-3-メトキシフェニル)-1,6-ヘプタジエン-3,5-ジオン |
クルクミン
クルクミン
出典: フリー百科事典『ウィキペディア(Wikipedia)』 (2024/07/02 09:38 UTC 版)
クルクミン (英: curcumin) は、ウコン(ターメリック、学名: Curcuma longa)などに含まれる黄色のポリフェノール化合物[2]。クルクミノイドに分類される。スパイスや食品領域の着色剤として利用され[注 1]、日本ではウコン色素として既存添加物(着色料)に指定されている。[3][4]ウコン由来のクルクミンは「医薬品の範囲に関する基準」では医薬品でないものに分類され[2]、効用を謳わない限りは食品扱いとなる。
注釈
出典
- ^ a b “HSDB: CURCUMIN”. TOXNET, National Library of Medicine (NLM). 2017年10月4日閲覧。
- ^ a b c d e f g クルクミン - 素材情報データベース<有効性情報>(国立健康・栄養研究所) 2016年8月3日閲覧
- ^ “既存添加物名簿収載品目リスト”. 日本食品化学研究振興財団 (2014年1月30日). 2017年11月6日閲覧。
- ^ “食品添加物関連情報 クルクミン”. 国立医薬品食品衛生研究所安全情報部. 2017年11月6日閲覧。
- ^ 平松, 茂樹 (2017). “「化学」の授業で色の変化を見る”. 化学と教育 65 (8): 396–399. doi:10.20665/kakyoshi.65.8_396 .
- ^ Methods for the Chemical Analysis of Water and Wastes (MCAWW) (EPA/600/4-79/020)
- ^ Manolova, Yana; Deneva, Vera; Antonov, Liudmil; at al (2014). “The effect of the water on the curcumin tautomerism: A quantitative approach”. Spectrochimica Acta 132A (1): 815–820. doi:10.1016/j.saa.2014.05.096.
- ^ J. Miłobȩdzka, St. v. Kostanecki, V. Lampe (1910). “Zur Kenntnis des Curcumins”. Berichte der deutschen chemischen Gesellschaft 43 (2): 2163–2170. doi:10.1002/cber.191004302168.
- ^ 坂元(佐々木)史歩、佐藤 恭子、阿部 雅美、杉本 直樹、米谷 民雄 (1998). “天然着色料ウコン色素の成分分析とクルクミンの光安定性 Components of Turmeric Oleoresin Preparations and Photo-stability of Curcumin”. 日本食品化学学会誌 Jpn. J. Food Chem. 5: 57-63. NAID 110007367140.
- ^ Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK (1997). “Stability of curcumin in buffer solutions and characterization of its degradation products”. J. Pharm. Biomed. Anal. 15 (12): 1867-1876. doi:10.1016/S0731-7085(96)02024-9. PMID 9278892.
- ^ Schmitt, B.; Holscher, D.; Schneider, B. (2000). “Variability of phenylpropanoid precursors in the biosynthesis of phenylphenalenones in Anigozanthos preissii”. Phytochemistry 53 (3): 331–337. doi:10.1016/S0031-9422(99)00544-0. PMID 10703053.
- ^ Gehlert, R.; Schoeppner, A.; Kindl, H. (1990). “Stilbene synthase from seedlings of Pinus sylvestris: purification and induction in response to fungal infection”. Molecular Plant-Microbe Interactions 3: 444–449. doi:10.1094/MPMI-3-444.
- ^ Kita, T.; Imai, S.; Sawada, H.; Kumagai, H.; Seto, H. (2008). “The biosynthetic pathway of curcuminoid in turmeric (Curcuma longa) as revealed by 13C-labeled precursors”. Biosci. Biotechnol. Biochem. 72: 1789–1798. PMID 18603793.
- ^ Katsuyama, Y.; Kita, T.; Funa, N.; Horinouchi, S. (2009). “Curcuminoid Biosynthesis by Two Type III Polyketide Synthases in the Herb Curcuma longa”. J. Biol. Chem. 284 (17): 11160–11170. doi:10.1074/jbc.M900070200. PMC 2670121. PMID 19258320 .
- ^ Katsuyama, Y.; Kita, T.; Horinouchi, S. (2009). “Identification and characterization of multiple curcumin synthases from the herb Curcuma longa”. FEBS Lett. 583 (17): 2799-2803. doi:10.1016/j.febslet.2009.07.029. PMID 19622354.
- ^ Srivastava KC, Bordia A, Verma SK (1995). “Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets”. Prostaglandins Leukot. Essent. Fatty Acids 52 (4): 223-227. PMID 7784468.
- ^ Aggarwal BB, Shishodia S (2004). “Suppression of the nuclear factor-κB activation pathway by spice-derived phytochemicals: reasoning for seasoning”. Ann. N. Y. Acad. Sci. 1030: 434-441. doi:10.1196/annals.1329.054. PMID 15659827.
- ^ “Chemoprevention of Colorectal Cancer - Database of agents & diets ranked by efficacy: A systematic review of experimental studies (men, rats, mice)”. Chemoprevention Database. 2011年11月17日閲覧。
- ^ Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005). “Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo”. J. Biol. Chem. 280 (7): 5892-5901. doi:10.1074/jbc.M404751200. PMID 15590663.
- ^ Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH (2006). “Curry consumption and cognitive function in the elderly”. Am. J. Epidemiol. 164 (9): 898-906. doi:10.1093/aje/kwj267. PMID 16870699.
- ^ Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS (1998). “Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers”. Planta Med. 64 (4): 353-356. doi:10.1055/s-2006-957450. PMID 9619120.
- ^ Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A (2007). “Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy”. J. Nanobiotechnology 5: 3. doi:10.1186/1477-3155-5-3. PMC 1868037. PMID 17439648 .
- ^ Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, Rock CL, Pruitt MA, Yang F, Hudspeth B, Hu S, Faull KF, Teter B, Cole GM, Frautschy SA (2008). “Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease”. J. Pharmacol. Exp. Ther. 326 (1): 196-208. doi:10.1124/jpet.108.137455. PMC 2527621. PMID 18417733 .
- ^ EP 20060004820, Giori, Andrea (Viale Ortles, 12, 20139 Milano, IT), Franceschi, Federico (Viale Ortles, 12, 20139 Milano, IT), published 2007-09-26, assigned to INDENA S.p.A. (Viale Ortles, 12, 20139 Milano, IT)
- ^ Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ (2007). “Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine”. Cancer Chemother. Pharmacol. 60 (2): 171–177. doi:10.1007/s00280-006-0355-x. PMID 17051370.
- ^ Yu, Hailong; Huang, Qingrong (2010). “Enhanced in vitro anti-cancer activity of curcumin encapsulated in hydrophobically modified starch”. Food Chemistry 119: 669-674. doi:10.1016/j.foodchem.2009.07.018.
- ^ Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T (2011). “Innovative preparation of curcumin for improved oral bioavailability”. Biol. Pharm. Bull. 34 (5): 660-665. doi:10.1248/bpb.34.660. PMID 21532153.
- ^ “Iron chelation in the biological activity of curcumin.”. Free Radical Biology and Medicine 40 (7). (2006). doi:10.1016/j.freeradbiomed.2005.11.003. PMID 16545682.
- ^ “Curcumin may impair iron status when fed to mice for six months”. Redox Biology 2. (2014). doi:10.1016/j.redox.2014.01.018. PMID 24634837 .
- ^ “Curcumin Attenuates Iron Accumulation and Oxidative Stress in the Liver and Spleen of Chronic Iron-Overloaded Rats”. PLoS One 10 (7): e0134156. (2015). doi:10.1371/journal.pone.0134156. PMID 26230491 .
- ^ “Iron and cancer: more ore to be mined”. Nature Reviews Cancer 13: p.342. (2013). doi:10.1038/nrc3495.
- ^ Kulkarni, SK; Dhir, A (2010). “An overview of curcumin in neurological disorders”. Indian Journal of Pharmaceutical Sciences 72 (2): 149. doi:10.4103/0250-474X.65012. PMC 2929771. PMID 20838516 .
- ^ Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ (February 2018). “Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis”. Br J Sports Med 52 (3): 167–175. doi:10.1136/bjsports-2016-097333. PMID 29018060.
- ^ Pharmacist’s Letter/Prescriber’s letter, ed (2006). Natural Medicine Comprehensive Database. ISBN 978-0978820510
- ^ Lal B, Kapoor AK, Asthana OP, Agrawal PK, Prasad R, Kumar P, Srimal RC (1999). “Efficacy of curcumin in the management of chronic anterior uveitis”. Phytother. Res. 13 (4): 318-322. PMID 10404539.
- ^ “Curcumin protects against cytotoxic and inflammatory effects of quartz particles but causes oxidative DNA damage in a rat lung epithelial cell line”. Toxicology and applied pharmacology 227 (1). (2008). doi:10.1016/j.taap.2007.10.002. PMID 18001810.
- ^ a b NIH (2011年5月6日). “MedlinePlus Supplements, Turmeric”. Natural Medicine Comprehensive Database Consumer Version. 2011年11月17日閲覧。
- ^ Iwata K, Iwasa M, Hara N, Matsumoto A, Kobayashi Y, Watanabe S, Adachi Y, Kaito M (2006). “Iron content and consumption of health foods by patients with chronic hepatitis C”. J. Gastroenterol. 41 (9): 919-920. doi:10.1007/s00535-006-1860-8. PMID 17048058.
- ^ Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY (2001). “Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions”. Anticancer Res. 21 (4B): 2895-2900. PMID 11712783.
- ^ WHO (2004年). “Evaluation of certain food additives and contaminants (Sixty-first report of the Joint FAO/WHO Expert Committee on Food Additives” (pdf). WHO Technical Report Series, No. 922. 2011年11月17日閲覧。
- ^ CURCUMIN (html). WHO FOOD ADDITIVES SERIES: 52 (Report). JECFA.
- ^ CURCUMIN (html). Summary of Evaluations (Report). JECFA.
- ^ Kawanishi, S. Oikawa, S. Murata, M. (2005). “Evaluation for safety of antioxidant chemopreventive agents”. Antioxid. Redox Signal. 7 (11-12): 1728-1739. doi:10.1089/ars.2005.7.1728. PMID 16356133.
- ^ Moos PJ, Edes K, Mullally JE, Fitzpatrick FA (2004). “Curcumin impairs tumor suppressor p53 function in colon cancer cells”. Carcinogenesis 25 (9): 1611-1617. doi:10.1093/carcin/bgh163. PMID 15090465.
- ^ Lois Swirsky Gold (2007年10月3日). “Turmeric (>98% curcurmin)”. Carcinogenic Potency Database Project. 2011年11月17日閲覧。
- ^ “3. 食器等の洗浄効果の確認検査”. 文部科学省. 2020年6月5日閲覧。
固有名詞の分類
- クルクミンのページへのリンク